In this study, we found that the MLN4924 inhibits Neddylation to block ERRβ ubiquitination and degradation, resulting in an accumulation of ERRβ in both ERα-positive and triple-negative breast cancer cells. Here, ESRRB is linked to triple-negative breast carcinoma.